1. PTH-132 High rates of clinical response are maintained after switching from originator to biosimilar infliximab. (June 2019) Authors: Haggarty, Rebecca; Waddell, Katy; Veryan, Jennifer; Nowell, Emma; Seenan, John Paul; Macdonald, Jonathan Journal: Gut Issue: Volume 68(2019)Supplement 2 Page Start: A101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTH-133 herapeutic drug monitoring supports clinical decision making when employed before and after biosimilar infliximab switching. (June 2019) Authors: Waddell, Katy; Haggarty, Rebecca; Veryan, Jennifer; Nowell, Emma; Seenan, John Paul; Macdonald, Jonathan Journal: Gut Issue: Volume 68(2019)Supplement 2 Page Start: A101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Real‐world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort. Issue 8 (5th March 2021) Authors: Plevris, Nikolas; Fulforth, James; Siakavellas, Spyros; Robertson, Andrew; Hall, Rebecca; Tyler, Amy; Jenkinson, Philip W; Campbell, Iona; Chuah, Cher Shiong; Kane, Claire; Veryan, Jennifer; Lam, Wai Liam; Saunders, Jayne; Kelly, Christopher; Gaya, Daniel; Jafferbhoy, Hasnain; Macdonald, Jonathan... Journal: Journal of gastroenterology and hepatology Issue: Volume 36:Issue 8(2021) Page Start: 2067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Recent advances in alcoholic hepatitis. Issue 2 (21st May 2019) Authors: Veryan, Jennifer; Forrest, EH Journal: Frontline gastroenterology Issue: Volume 11:Issue 2(2020) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗